Comparative outcome analysis of ABO-incompatible and positive crossmatch renal transplantation: A single-center experience

Transplantation

Volumn 87, Issue 12, 2009, Pages 1889-1896

  Padmanabhan, Anand ^a   Ratner, Lloyd E ^a   Jhang, Jeffrey S ^a   Duong, Jimmy K ^a   Markowitz, Glen S ^a   Vasilescu, Elena R ^a   Crew, Russell J ^a   Schwartz, Joseph ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

ABO incompatibility; Positive crossmatch; Tolerance

Indexed keywords

CREATININE; DACLIZUMAB; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT FAILURE; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PATIENT MONITORING; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; AUTOANTIBODIES; BLOOD GROUP INCOMPATIBILITY; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 67649586576     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a76ae1     Document Type: Article

References (24)

1. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089.
2. Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific crossmatch:Asingle center's perspective. Pediatr Transplant 2004; 8: 535.
3. Kayler LK, Colombe B, Farber JL, et al. Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatch. Clin Transplant 2004; 18: 737.
4. Tyden G, Donauer J, Wadstrom J, et al. Implementation of a protocol for ABO-incompatible kidney transplantation-A three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153.
5. Ratner LE, Ciseck LJ, Moore RG, et al. Laparoscopic live donor nephrectomy. Transplantation 1995; 60: 1047.
6. Ratner LE, Montgomery RA, Kavoussi LR. Laparoscopic live donor nephrectomy: The four year Johns Hopkins University experience. Nephrol Dial Transplant 1999; 14: 2090.
7. Crew RJ, Ratner LE. Overcoming immunologic incompatibility: Transplanting the difficult to transplant patient. Semin Dial 2005; 18: 474.
8. Hume DM, Merrill JP, Miller BF, et al. Experiences with renal homotransplantation in the human: Report of nine cases. J Clin Invest 1955; 34: 327.
9. Kissmeyer-Nielsen F, Olsen S, Petersen VP, et al. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662.
10. Ishida H, Miyamoto N, Shirakawa H, et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation- Single center analysis. Am J Transplant 2007; 7: 825.
11. Vasilescu ER, Ho EK, Colovai AI, et al. Alloantibodies and the outcome of cadaver kidney allografts. Hum Immunol 2006; 67: 597.
12. Meier-Kriesche HU, Schold JD. The impact of pretransplant dialysis on outcomes in renal transplantation. Semin Dial 2005; 18: 499.
13. Kobayashi T, Saito K. A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee. Xenotransplantation 2006; 13: 136.
14. AuBuchon JP, de Wildt-Eggen J, Dumont LJ. Reducing the variation in performance of antibody titrations. Arch Pathol Lab Med 2008; 132: 1194.
15. Milland J, Sandrin MS. ABO blood group and related antigens, natural antibodies and transplantation. Tissue Antigens 2006; 68: 459.
16. Humar A, Durand B, Gillingham K, et al. Living unrelated donors in kidney transplants: Better long-term results than with non-HLAidentical living related donors? Transplantation 2000; 69: 1942.
17. Winters JL, Gloor JM, Pineda AA, et al. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apher 2004; 19: 79.
18. Montgomery RA, Locke JE. ABO-incompatible transplantation: Less may be more. Transplantation 2007; 84 (12 suppl): S8.
19. Gloor JM, DeGoey SR, Pineda AA, et al. Overcoming a positive crossmatch in living-donor kidney transplantation.AmJ Transplant 2003; 3: 1017.
20. Schweitzer EJ, Wilson JS, Fernandez-Vina M, et al. A high panelreactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 2000; 70: 1531.
21. Schwartz J, Stegall MD, Kremers WK, et al. Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation. Transplantation 2006; 82: 155.
22. Gloor JM, Lager DJ, Fidler ME, et al. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005; 80: 1572.
23. Maloney DG, Grillo-Lopez AJ, White CA, et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997; 90: 2188.
24. Segev DL, Gentry SE, Warren DS, et al. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005; 293: 1883.